Novo, Prime in outcomes-based Victoza contract

Novo Nordisk A/S (CSE:NOVOB; NYSE:NVO) signed an outcomes-based contract with PBM Prime Therapeutics LLC (Eagan, Minn.) for

Read the full 176 word article

User Sign In